Auro-canagliflozin: Affected Lots Are Labelled With The Incorrect Din Found On The Blister Card.
Auro-Canagliflozin tablets are being recalled because certain batches have incorrect drug identification numbers (DINs) printed on the blister card packaging. This affects Auro-Canagliflozin products distributed across Canada. The incorrect labeling is classified as a Class III safety concern.
- Product
- Auro-Canagliflozin
- Reason
- Product safety concern
- Classification
- Class III
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2026-03-31
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/e166bc26-ec4f-4c09-a669-f773165c113c